Document is current
Any future updates will be listed below
-
Authors
Proietti, Marco https://orcid.org/0000-0003-1452-2478
Romiti, Giulio Francesco https://orcid.org/0000-0002-3788-8942
- License Information
-
More Information
Article History
First Online: 7 January 2026
Competing interests
: M.P. declares speaker activity for Pfizer and BMS/JJ Alliance and consulting activity for Regeneron Pharmaceuticals; M.P. is also the Italian national principal investigator of the AFFIRMO project on multimorbidity in atrial fibrillation, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant 899871. G.F.R. declares consultancy for Boehringer Ingelheim and an educational grant from Anthos, outside of this work. No fees are directly received personally.
